AKT1 and acute myeloid leukemia: In addition, PI3K/Akt and MAPK pathways have also been reported to be constitutively activated in leukemic blast cells from patients with acute myeloid leukemia (AML) and contribute to sustain proliferation, inhibit apoptosis, and elicit transformation.12, 13